Study Summary
This trial will study how long donated and stored red blood cells survive in a person's circulation.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: Up to 12 months
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Biotin-Labeled Red Blood Cell (RBC) Infusion
1 of 1
Experimental Treatment
8 Total Participants · 1 Treatment Group
Primary Treatment: Biotin-Labeled Red Blood Cells (RBCs) · No Placebo Group · Phase 1
Trial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 65 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is there precedent for the use of Biotin-Labeled Red Blood Cells (RBCs) in medical research?
"Currently, there are 5 trials related to Biotin-Labeled Red Blood Cells (RBCs) in progress, one of which is at the advanced Phase 3 stage. These research projects can be found across seven different sites with many based in Bethesda, Maryland." - Anonymous Online Contributor
Are there any openings left for enrolment in this experiment?
"This clinical trial, which was initially publicized on November 1st 2017, is now enrolling participants. Updated information regarding the study was last posted to clinicaltrials.gov on January 26th 2022." - Anonymous Online Contributor
Are individuals aged 25 or above eligible for enrollment in this experiment?
"According to the study's eligibility requirements, potential participants must be aged between 18-65." - Anonymous Online Contributor
Is there any hazard associated with Biotin-Labeled Red Blood Cells (RBCs) for human consumption?
"Our group at Power determined that Biotin-Labeled Red Blood Cells (RBCs) is a low risk intervention, with score of 1. This assessment was made due to the fact it's currently within Phase 1 trials and has limited data supporting its safety or efficacy." - Anonymous Online Contributor
Am I eligible to contribute to this research endeavor?
"To be considered for this medical trial, individuals must have anemia and fall within the age range of 18 to 65. A total of 8 participants are needed." - Anonymous Online Contributor
How many participants will be included in the current clinical trial?
"Affirmative. Clinicaltrials.gov has reports that this trial, which was published on 11th January 2017, is currently accepting applications. A total of 8 participants are needed for the study and only one research centre will be involved in its execution." - Anonymous Online Contributor